These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 29669380

  • 1. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N, Ahmad R, Alam MA, Ahmad FJ.
    Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
    [Abstract] [Full Text] [Related]

  • 2. Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment.
    Ahmad N, Al-Subaiec AM, Ahmad R, Sharma S, Alam MA, Ashafaq M, Abdur Rub R, Ahmad FJ.
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):475-490. PubMed ID: 30739499
    [Abstract] [Full Text] [Related]

  • 3. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X, Chi N, Tang X.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
    [Abstract] [Full Text] [Related]

  • 4. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):6-15. PubMed ID: 22561106
    [Abstract] [Full Text] [Related]

  • 5. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Drug Dev Ind Pharm; 2019 Aug 30; 45(8):1342-1350. PubMed ID: 31094571
    [Abstract] [Full Text] [Related]

  • 6. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
    Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M, Iqbal Z, Ahmad FJ.
    Int J Biol Macromol; 2016 Oct 30; 91():640-55. PubMed ID: 27264648
    [Abstract] [Full Text] [Related]

  • 7. Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route.
    Mittal D, Md S, Hasan Q, Fazil M, Ali A, Baboota S, Ali J.
    Drug Deliv; 2016 Oct 30; 23(1):130-9. PubMed ID: 24786489
    [Abstract] [Full Text] [Related]

  • 8. Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia.
    Ahmad N, Ahmad R, Alam MA, Samim M, Iqbal Z, Ahmad FJ.
    Int J Biol Macromol; 2016 Jul 30; 88():320-32. PubMed ID: 26976069
    [Abstract] [Full Text] [Related]

  • 9. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
    Alex AT, Joseph A, Shavi G, Rao JV, Udupa N.
    Drug Deliv; 2016 Sep 30; 23(7):2144-2153. PubMed ID: 25544603
    [Abstract] [Full Text] [Related]

  • 10. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS, Farid RM, ElGamal SS.
    Drug Dev Ind Pharm; 2015 Sep 30; 41(12):2055-68. PubMed ID: 26133084
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S, Ali J, Vohora D, Najmi AK, Akhtar M.
    J Drug Target; 2021 Feb 30; 29(2):199-216. PubMed ID: 32876502
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
    Liu S, Ho PC.
    J Pharm Pharmacol; 2017 Nov 30; 69(11):1495-1501. PubMed ID: 28809432
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, Wu Z, Sun K.
    Int J Nanomedicine; 2018 Nov 30; 13():705-718. PubMed ID: 29440896
    [Abstract] [Full Text] [Related]

  • 18. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B, Khunt D, Misra M, Padh H.
    Int J Biol Macromol; 2016 Aug 30; 89():206-18. PubMed ID: 27130654
    [Abstract] [Full Text] [Related]

  • 19. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.
    Belgamwar A, Khan S, Yeole P.
    Artif Cells Nanomed Biotechnol; 2018 Mar 30; 46(2):374-386. PubMed ID: 28423949
    [Abstract] [Full Text] [Related]

  • 20. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D, Fazil M, Ali MM, Baboota S, Ali J.
    Drug Deliv; 2015 Mar 30; 22(6):823-36. PubMed ID: 24725026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.